Health Care & Insurance  September 13, 2019

PanTheryx adds Dr. Oz to board

BOULDER  — PanTheryx Inc. is adding daytime talk show host Dr. Mehmet Oz, known just as “Dr. Oz,” to its corporate board.

In a press release Friday, the Boulder-based biologics company said Oz will primarily act as an adviser on company strategy.

PanTheryx makes medical foods and treatments for gastrointestinal infections and bases those products on colostrum, the first milk produced by mammals after they give birth. Newborn animals need colostrum to gain passive immunity to disease.

SPONSORED CONTENT

Solar Operations and Maintenance for Commercial Properties

One key qualification to consider when selecting a solar partner to install your system is whether they have an Operations and Maintenance (O&M) or service department. Since solar is a long-term asset with an expected lifecycle of 30 plus years, ongoing O&M should be considered up front. A trusted O&M partner will maximize your system’s energy output and therefor the return on your investment.

The company last landed a $50 million investment from New York-based investment firm Perceptive Partners in June. CEO Mark Braman previously told BizWest the company plans to start clinical trials of its medicinal foods candidates with the U.S. Food and Drug Administration by the end of the year, and to have biologic treatments in trials by Q1 2020.

Last year, PanTheryx’s chief medical officer Mark Grabowsky penned a post sponsored by the company on Dr. Oz’s website promoting colostrum.

BOULDER  — PanTheryx Inc. is adding daytime talk show host Dr. Mehmet Oz, known just as “Dr. Oz,” to its corporate board.

In a press release Friday, the Boulder-based biologics company said Oz will primarily act as an adviser on company strategy.

PanTheryx makes medical foods and treatments for gastrointestinal infections and bases those products on colostrum, the first milk produced by mammals after they give birth. Newborn animals need colostrum to gain passive immunity to disease.

The company last landed a $50 million investment from New York-based investment firm…

Ken Amundson
Ken Amundson is managing editor of BizWest. He has lived in Loveland and reported on issues in the region since 1987. Prior to Colorado, he reported and edited for news organizations in Minnesota and Iowa. He's a parent of two and grandparent of four, all of whom make their homes on the Front Range. A news junkie at heart, he also enjoys competitive sports, especially the Rapids.
Sign up for BizWest Daily Alerts